Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 4,110.00
-25.00 (-0.60%)
At close: Aug 11, 2026
Cellromax Science Revenue
Cellromax Science had revenue of 4.71B KRW in the quarter ending March 31, 2026, a decrease of -20.42%. This brings the company's revenue in the last twelve months to 20.98B, down -6.17% year-over-year. In the year 2025, Cellromax Science had annual revenue of 22.18B with 2.56% growth.
Revenue (ttm)
20.98B
Revenue Growth
-6.17%
P/S Ratio
2.16
Revenue / Employee
599.32M
Employees
35
Market Cap
45.38B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.18B | 553.61M | 2.56% |
| Dec 31, 2024 | 21.63B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.